Munnely, Kevin

CEO, Gen9


Kevin Munnelly has over 20 years experience with molecular biology, chemistry, software, instrument development, and statistical analysis. Prior to Gen9, he was a Leader and General Manager in the Next Generation qPCR business at Life Technologies where he was responsible for a multimillion dollar business segment as well as development of custom genomics solutions through collaborations with end user scientists. Prior to Life Technologies, Mr. Munnelly was Vice President and General Manager of BioTrove Inc, which was acquired by Life Technologies in 2009. At BioTrove, he led the research, development, manufacturing and commercial organizations. Prior to BioTrove, Mr. Munnelly was a Senior Manager of the Platform Technology group at Millennium Pharmaceuticals which developed new technologies for drug discovery, development, personalized medicine and biotherapeutics manufacturing. Earlier in his career, he had many different scientific roles in drug discovery, assay development, statistical analysis and platform development. He holds an A.B. with honors from Bowdoin College in Biochemistry and Molecular Biology and an MBA in Entrepreneurship, Magna Cum Laude, from Babson College.

Listen to an interview with Kevin